Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
Historik

Vælg chat via ovenstående menu
Luk reklame

DANMARKS STØRSTE INVESTORSITE MED DEBAT, CHAT OG NYHEDER

Health Canada Approves Johnson & Johnson’s COVID-19 Vaccine

25/11 07:30

Health Canada has authorized the single-shot COVID-19 vaccine of Janssen, a Johnson & Johnson (JNJ) company, to prevent COVID-19 in individuals aged 18 years and older. 

Health Canada’s authorization was based on the scientific evidence provided by the company, which included initial data from the Phase 3 ENSEMBLE study. The data demonstrated the efficacy of the vaccine at 85% in preventing the disease, and showed protection against COVID-19 related hospitalization and death, beginning 28 days after vaccination. 

Notably, the Phase 3 ENSEMBLE study was designed to evaluate the safety and efficacy of the company’s vaccine in protecting against both moderate and severe COVID-19 disease. (See Johnson & Johnson stock charts on TipRanks) 

Official Comments 

The Global Head, Janssen Research & Development at Johnson & Johnson, Mathai Mammen, said, “As vaccination rates continue to climb, a vaccine that prevents severe disease and protects against COVID-related hospitalization and death ...

Læs hele historien